Abstract The goal of the research was to improve photocatalytic activity of WO₃ by Cu doping to use for tetracycline decomposition. Firstly, the Cu dopant worked as nuclei for the crystallization of WO₃ leading to an increase in growth and sizes of formed crystals. However, the incorporation of Cu dopants in the WO₃ induced significant deviation into the WO₃ lattice inhibiting agglomeration of the WO₃ crystals to form large particles. Therefore, the crystal sizes of Cu-WO₃ were bigger than the WO₃ crystals, however, the Cu-WO₃ particles compared to WO₃ particles were smaller. By existing in the WO₃ lattice, the Cu dopant created an intermediate band to decrease band-gap energy and to boost electron-hole separation of the WO₃. Therefore, the synthesized Cu-WO₃ effectively generated large electrons and holes for the decomposition of tetracycline under visible light excitation. The study investigated that 3Cu-WO₃, in which the Cu doping ratio was 3% mole, showed the highest tetracycline decomposition efficiency (∼79.5%). This was due to the doping of Cu into the WO₃ lattice reached a limit, excess that limitation, Cu precursor formed CuO distributing on the WO₃ surface to eclipse light reaching the material leading to decrease in electron-hole separation rate due to limited light absorption or decrease in photocatalytic degradation. Finally, the Cu-WO₃ exhibited novel stability during the degradation of tetracycline.
No takes yet. Share an insight, caveat, or question.
Khoa et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: